Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquale Fatuzzo

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Kidney & Blood Pressure Research|July 1, 2006
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal diseaseSalvatore Santo Signorelli, Pasquale Fatuzzo, Francesco Rapisarda, et al.
Journal of Hypertension|June 21, 2003
Neuropeptide Y, left ventricular mass and function in patients with end stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, et al.
Journal of Hypertension|August 14, 2008
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patientsFrancesca Mallamaci, Francesco A Benedetto, Giovanni Tripepi, et al.
European Journal of Internal Medicine|August 24, 2017
Pulse wave velocity differs between ulcerative colitis and chronic kidney diseaseLuca Zanoli, Paolo Lentini, Pierre Boutouyrie, et al.
Seminars in Nephrology|November 22, 2005
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD studyLuca De Nicola, Roberto Minutolo, Pasquale Zamboli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 9, 2020
[Therapeutic options to reduce arterial stiffness in chronic kidney disease]Concetto Sessa, Pietro Castellino, Giovanni G Battaglia, et al.
Journal of the American Society of Nephrology : JASN|September 30, 2003
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, et al.
Kidney International|October 10, 2002
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patientsFrancesca Mallamaci, Carmine Zoccali, Saverio Parlongo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patientsFrancesca Mallamaci, Carmine Zoccali, Saverio Parlongo, et al.
Circulation|March 20, 2002
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Saverio Parlongo, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Kidney & Blood Pressure Research|July 1, 2006
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal diseaseSalvatore Santo Signorelli, Pasquale Fatuzzo, Francesco Rapisarda, et al.
Journal of Hypertension|June 21, 2003
Neuropeptide Y, left ventricular mass and function in patients with end stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, et al.
Journal of Hypertension|August 14, 2008
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patientsFrancesca Mallamaci, Francesco A Benedetto, Giovanni Tripepi, et al.
European Journal of Internal Medicine|August 24, 2017
Pulse wave velocity differs between ulcerative colitis and chronic kidney diseaseLuca Zanoli, Paolo Lentini, Pierre Boutouyrie, et al.
Seminars in Nephrology|November 22, 2005
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD studyLuca De Nicola, Roberto Minutolo, Pasquale Zamboli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 9, 2020
[Therapeutic options to reduce arterial stiffness in chronic kidney disease]Concetto Sessa, Pietro Castellino, Giovanni G Battaglia, et al.
Journal of the American Society of Nephrology : JASN|September 30, 2003
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, et al.
Kidney International|October 10, 2002
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patientsFrancesca Mallamaci, Carmine Zoccali, Saverio Parlongo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patientsFrancesca Mallamaci, Carmine Zoccali, Saverio Parlongo, et al.
Circulation|March 20, 2002
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal diseaseCarmine Zoccali, Francesca Mallamaci, Saverio Parlongo, et al.
Pageof 6